PppApG

• Description :

  PppApG is a starting product of both vRNA (viral RNA) and cRNA (complementary RNA) synthesis. pppApG can be used for influenza virus research[1].

• UNSPSC :

  12352005

• Target :

  DNA/RNA Synthesis

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/pppapg.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O[C@H]([C@@H]1O[P](OC[C@H]([C@H]2O)O[C@](N3C(NC(N)=NC4=O)=C4N=C3)([H])[C@@H]2O)(O)=O)[C@](O[C@@H]1CO[P](O[P](O[P](O)(O)=O)(O)=O)(O)=O)([H])N5C6=NC=NC(N)=C6N=C5

• Molecular Formula :

  C20H28N10O20P4

• Molecular Weight :

  852.39

• References & Citations :

  [1]Te Velthuis AJ, et al. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol. 2016 Aug;14 (8) :479-93.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [68892-47-7]